Home / Conditions / Type 1 Diabetes
Type 1 Diabetes: when insurers say no, reviewers often say yes
In 81 published external-review decisions involving type 1 diabetes, independent physician reviewers overturned the insurer’s denial 80.2% of the time.
Published decisions
81
2001–2026
Overturned
80.2%
65 denials reversed
Most-fought treatments for type 1 diabetes
What insurers denied — and how those fights ended.
| Treatment | Decisions | Overturned |
|---|---|---|
| Ozempic | 15 | 80% |
How to use this in your appeal
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for type 1 diabetes was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.